Tacrolimus as a therapeutic alternative in psoriasis: A retrospective observational study

被引：1
|
作者：
Baveja, Sukriti [1 ]
Neema, Shekhar [2 ]
Pathania, Vikas [2 ]
Kothari, Rohit [2 ]
机构：
[1] Mil Hosp, Dept Dermatol, Agra, Uttar Pradesh, India
[2] Armed Forces Med Coll, Dept Dermatol, Pune, Maharashtra, India
来源：
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY | 2022年 / 88卷 / 02期
关键词：
FK-506;
D O I：
10.25259/IJDVL_1229_20
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [41] Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus
    Lubaki, L. J.
    Ghanem, G.
    Vereecken, P.
    Fouty, E.
    Benammar, L.
    Vadoud-Seyedi, J.
    Dell'Anna, M. L.
    Briganti, S.
    Picardo, M.
    Heenen, M.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2010, 302 (02) : 131 - 137
  • [42] Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in AChR-myasthenia gravis patients
    Li, Yingkai
    Chen, Pei
    Huang, Xin
    Huang, Hao
    Ma, Qian
    Lin, Zhongqiang
    Qiu, Li
    Ou, Changyi
    Liu, Weibin
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 396
  • [43] Evaluation of Tacrolimus Trough Level in Patients Who Developed Post-transplant Diabetes Mellitus After Kidney Transplantation: A Retrospective Single-Center Study in Saudi Arabia
    Ajabnoor, Alyaa
    Nasser, Mohannad
    Khan, Naveed
    Habhab, Wael
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (10) : 3160 - 3167
  • [44] Tacrolimus treatment after short-term intravenous methylprednisolone in incipient minimal change disease for adults: A retrospective analysis
    Shen, Ya
    Sheng, Xiaoxiao
    Zhang, Xinyue
    Dong, Yijun
    Zhai, Yaling
    Gao, Jingge
    Chen, Yazhuo
    Gao, Ge
    Feng, Yuhua
    Yin, Liugen
    Wu, Xueying
    Li, Ruman
    Wang, Yun
    Zhang, Huiya
    Chen, Ziyi
    Cheng, Genyang
    NEPHROLOGIE & THERAPEUTIQUE, 2022, 18 (06): : 549 - 556
  • [45] Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience
    Nuki, Yoichiro
    Esaki, Motohiro
    Asano, Kouichi
    Maehata, Yuji
    Umeno, Junji
    Moriyama, Tomohiko
    Nakamura, Shotaro
    Matsumoto, Takayuki
    Kitazono, Takanari
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (06) : 700 - 705
  • [46] Long-terms therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis
    Tada, Masayoshi
    Shimohata, Takayoshi
    Tada, Mari
    Oyake, Mutsuo
    Igarashi, Shuichi
    Onodera, Osamu
    Naruse, Satoshi
    Tanaka, Keiko
    Tsuji, Shoji
    Nishizawa, Masatoyo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 247 (01) : 17 - 20
  • [47] Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve-based monitoring?
    van Gelder, Teun
    Gelinck, Armin
    Meziyerh, Soufian
    de Vries, Aiko P. J.
    Moes, Dirk Jan A. R.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [48] Therapeutic time window of tacrolimus (FK506) in a nonhuman primate stroke model: Comparison with tissue plasminogen activator
    Furuichi, Yasuhisa
    Maeda, Masashi
    Matsuoka, Nobuya
    Mutoh, Seltaro
    Yanagihara, Takehiko
    EXPERIMENTAL NEUROLOGY, 2007, 204 (01) : 138 - 146
  • [49] Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation
    Peterka, Tanja Rozman
    Grahek, Rok
    Hren, Jure
    Bastarda, Andrej
    Bergles, Jure
    Urleb, Uros
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 110 : 67 - 75
  • [50] Primary immunosuppression with tacrolimus in renal transplantation:: A multicenter, open-label study
    Mancilla, UE
    Martínez, NB
    Alberú, J
    Diliz, H
    ADVANCES IN THERAPY, 1999, 16 (05) : 210 - 218
12345